Search
for
Sort by
Research 61–90 of 775
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- 44096 Efficacy in Subgroups related to Disease Characteristics in Patients with Alopecia Areata from BRAVE-AA1 and BRAVE-AA2
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Ivarmacitinib in atopic dermatitis presenting with prurigo nodularis-like lesions and alopecia areata: a case report
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- 0480 Upadacitinib monotherapy for treatment of pyoderma gangrenosum: A case series
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- S3886 Concurrent Management of Crohn's Ileitis and Alopecia Universalis With Upadacitinib
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Upadacitinib for the treatment of alopecia areata – A case report
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata